PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Aix-Marseille université, AP-HM, INSERM, CNRS, CRCM, hôpital Nord, service d\'oncologie multidisciplinaire et innovations thérapeutiques, Marseille, France; Institut du cancer de Montpellier, Montpellier, France.\', \'Aix-Marseille université, AP-HM, INSERM, CNRS, CRCM, hôpital Nord, service d\'oncologie multidisciplinaire et innovations thérapeutiques, Marseille, France.\', \'Aix-Marseille université, AP-HM, INSERM, CNRS, CRCM, hôpital Nord, service d\'oncologie multidisciplinaire et innovations thérapeutiques, Marseille, France. Electronic address: pascale.tomasini@ap-hm.fr.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0761-8425(21)00307-710.1016/j.rmr.2021.06.005
?:hasPublicationType
?:journal
  • Revue des maladies respiratoires
is ?:pmid of
?:pmid
?:pmid
  • 34246519
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.243
?:rankingScore_hIndex
  • 25
is ?:relation_isRelatedTo_publication of
?:title
  • [Immunotherapy adaptation in lung cancer during the COVID-19 pandemic].
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all